RGC short interest
Regencell Bioscience Holdings Limited · Healthcare · Drug Manufacturers - Specialty & Generic · settlement date 2026-09-30
| Shares short | 656,182 |
|---|---|
| Change vs prior report | -145,062 (-18.1%) |
| Change over six months | -6.3% |
| Days to cover | 7.29 (sector: 3.78) |
| Average daily volume | 89,957 |
| Rank in Healthcare | #229 of 922 by days to cover |
RGC short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 656,182 | -18.1% | 7.29 | 89,957 |
| 2026-09-15 | 801,244 | -15.8% | 3.08 | 259,827 |
| 2026-08-31 | 951,697 | -3.9% | 8.10 | 117,503 |
| 2026-08-14 | 990,338 | +9.7% | 4.74 | 208,774 |
| 2026-07-31 | 903,042 | -2.9% | 4.05 | 222,902 |
| 2026-07-15 | 930,076 | +22.2% | 1.15 | 808,556 |
| 2026-06-30 | 760,774 | +1.2% | 2.03 | 374,717 |
| 2026-06-15 | 751,560 | -3.5% | 7.82 | 96,144 |
| 2026-05-29 | 779,012 | -2.3% | 8.44 | 92,310 |
| 2026-05-15 | 797,139 | +3.2% | 7.15 | 111,501 |
| 2026-04-30 | 772,547 | -7.0% | 7.99 | 96,664 |
| 2026-04-15 | 830,632 | +18.6% | 3.43 | 242,253 |
| 2026-03-31 | 700,509 | +15.5% | 5.23 | 134,009 |
| 2026-03-13 | 606,522 | -4.5% | 5.47 | 110,860 |
| 2026-02-27 | 634,850 | -5.3% | 7.16 | 88,606 |
| 2026-02-13 | 670,710 | -13.3% | 4.01 | 167,394 |
| 2026-01-30 | 773,634 | -16.3% | 1.42 | 542,921 |
| 2026-01-15 | 924,708 | -28.1% | 1.00 | 1,378,413 |
| 2025-12-31 | 1,285,978 | +6.0% | 3.55 | 361,817 |
| 2025-12-15 | 1,212,627 | +2.4% | 4.42 | 274,161 |
| 2025-11-28 | 1,184,257 | -2.1% | 8.99 | 131,661 |
| 2025-11-14 | 1,209,795 | -6.2% | 9.30 | 130,025 |
| 2025-10-31 | 1,289,935 | -5.0% | 11.49 | 112,274 |
| 2025-10-15 | 1,358,115 | -11.5% | 4.83 | 281,472 |
| 2025-09-30 | 1,533,836 | -8.7% | 8.39 | 182,811 |
import finzdata as yf
yf.Ticker("RGC").short_interest # every report since 2017
yf.Client().short_interest(["RGC"], start="2018-01-01")Healthcare short interest · RGC price history · Who owns RGC · All short interest